Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Research

Characteristics and risk factors of pharmacist misconduct in New Zealand: a retrospective nationwide analysis

Authors: Yufeng Wang, Sanyogita (Sanya) Ram, Shane Scahill

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

Professional misconduct has evolved into a worldwide concern, involving various forms and types of behaviours that contribute to unsafe practices. This study aimed to provide insights into the patterns characterising pharmacist misconduct and uncover underlying factors contributing to such instances in New Zealand.

Methods

This research examined all cases of pharmacist misconduct sourced from the Health Practitioners Disciplinary Tribunal (HPDT) database in New Zealand since 2004. Characteristics of the sampled pharmacists and cases were extracted, followed by a systematic coding of the observed misconduct issues. Identification of risk factors was accomplished through content analysis techniques, enabling an assessment of their prevalence across various forms of misconduct.

Results

The dataset of pharmacist misconduct cases comprised 58 disciplinary records involving 55 pharmacists. Seven types of misconduct were identified, with the most commonly observed being quality and safety issues related to drug, medication and care, as well as criminal conviction. A total of 13 risk factors were identified and systematically classified into three categories: (1) social, regulatory, and external environmental factors, (2) systematic, organisational, and practical considerations in the pharmacy, and (3) pharmacist individual factors. The most frequently mentioned and far-reaching factors include busyness, heavy workload or distraction; health impairment issues; and life stress or challenges.

Conclusions

The patterns of pharmacist misconduct are complicated, multifaceted, and involve complex interactions among risk factors. Collaborative efforts involving individual pharmacists, professional bodies, responsible authorities, policy-makers, health funders and planners in key areas such as pharmacist workload and well-being are expected to mitigate the occurrence of misconduct. Future research should seek to uncover the origins, manifestations, and underlying relationships of various contributing factors through empirical research with appropriate individuals.
Literature
1.
Searle RH, Rice C. Making an impact in healthcare contexts: insights from a mixed-methods study of professional misconduct. Eur J Work Organ Psychol. 2021;30:470–81.CrossRef
2.
3.
4.
Sklar T, Taouk Y, Studdert D, Spittal M, Paterson R, Bismark M. Characteristics of lawyers who are subject to complaints and Misconduct findings. J Empir Leg Stud. 2019;16:318–42.CrossRef
5.
Spittal MJ, Bismark MM, Studdert DM. The PRONE score: an algorithm for predicting doctors’ risks of formal patient complaints using routinely collected administrative data. BMJ Qual Saf. 2015;24:360–8.CrossRefPubMedPubMedCentral
6.
Spittal MJ, Bismark MM, Studdert DM. Identification of practitioners at high risk of complaints to health profession regulators. BMC Health Serv Res. 2019;19:380.CrossRefPubMedPubMedCentral
7.
Austin EE, Do V, Nullwala R, Fajardo Pulido D, Hibbert PD, Braithwaite J, et al. Systematic review of the factors and the key indicators that identify doctors at risk of complaints, malpractice claims or impaired performance. BMJ Open. 2021;11:e050377.CrossRefPubMedPubMedCentral
8.
Bismark MM, Spittal MJ, Gurrin LC, Ward M, Studdert DM. Identification of doctors at risk of recurrent complaints: a national study of healthcare complaints in Australia. BMJ Qual Saf. 2013;22:532–40.CrossRefPubMedPubMedCentral
9.
Studdert DM, Bismark MM, Mello MM, Singh H, Spittal MJ. Prevalence and characteristics of Physicians Prone to Malpractice Claims. N Engl J Med. 2016;374:354–62.CrossRefPubMed
10.
Croft E, Clark MT, Efstathiou N, Bradbury-Jones C. A focused mapping review and synthesis of a priori risk factors associated with medical misconduct. BMJ Open Qual. 2019;8:e000538.CrossRefPubMedPubMedCentral
11.
Carlson JN, Foster KM, Pines JM, Corbit CK, Ward MJ, Hydari MZ, et al. Provider and practice factors associated with emergency physicians’ being named in a malpractice claim. Ann Emerg Med. 2018;71:157–164e4.CrossRefPubMed
12.
Guidera M, McCool W, Hanlon A, Schuiling K, Smith A. Midwives and liability: results from the 2009 nationwide survey of certified nurse-midwives and certified midwives in the United States. J Midwifery Womens Health. 2012;57:345–52.CrossRefPubMed
13.
Schaffer AC, Babayan A, Yu-Moe CW, Sato L, Einbinder JS. The effect of clinical volume on annual and per-patient encounter medical malpractice claims risk. J Patient Saf. 2021;17:e995–1000.CrossRefPubMed
14.
Millbank J. Serious misconduct of health professionals in disciplinary tribunals under the National Law 2010-17. Aust Health Rev. 2020;44:190–9.CrossRefPubMed
15.
Surgenor LJ, Diesfeld K, Ip M, Kersey K. New Zealand’s health practitioners disciplinary Tribunal: an analysis of decisions 2004–2014. J Law Med. 2016;24:239–51.PubMed
16.
Surgenor LJ, Diesfeld K, Kersey K, Kelly O, Rychert M. Fifteen years on: what patterns continue to emerge from New Zealand’s health practitioners disciplinary Tribunal? J Law Med. 2020;28:165–78.PubMed
17.
Elkin KJ, Spittal MJ, Elkin DJ, Studdert DM, Elkin KJ, Spittal MJ, et al. Doctors disciplined for professional misconduct in Australia and New Zealand, 2000–2009. Med J Aust. 2011;194:452–6.CrossRefPubMed
18.
19.
20.
Bengtsson M. How to plan and perform a qualitative study using content analysis. NursingPlus Open. 2016;2:8–14.CrossRef
21.
Källberg A-S, Göransson KE, Östergren J, Florin J, Ehrenberg A. Medical errors and complaints in emergency department care in Sweden as reported by care providers, healthcare staff, and patients– a national review. Eur J Emerg Med. 2013;20:33–8.CrossRefPubMed
22.
Sparring Björkstén K, Bergqvist M, Andersén-Karlsson E, Benson L, Ulfvarson J, Björkstén KS. Medication errors as malpractice-a qualitative content analysis of 585 medication errors by nurses in Sweden. BMC Health Serv Res. 2016;16:1–8.
23.
Lincoln YS, Guba EG. But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New Dir Program Eval. 1986;30:73–84.CrossRef
24.
Thomas DR. A General Inductive Approach for analyzing qualitative evaluation data. Am J Eval. 2006;27:237–46.CrossRef
25.
Jacobs S, Hassell K, Seston E, Potter H, Schafheutle E. Identifying and managing performance concerns in community pharmacists in the UK. J Health Serv Res Policy. 2013;18:144–50.CrossRefPubMed
26.
Walton M, Kelly PJ, Chiarella EM, Carney T, Bennett B, Nagy M, et al. Profile of the most common complaints for five health professions in Australia. Aust Health Rev. 2020;44:15–23.CrossRefPubMed
27.
Surgenor L, Diesfeld K, Rychert M, Kelly O, Kersey K. Criminal Convictions of Disciplined Health Practitioners in New Zealand. J Law Med. 2022;29:117–28.PubMed
28.
Peerally MF, Carr S, Waring J, Martin G, Dixon-Woods M. A content analysis of contributory factors reported in serious incident investigation reports in hospital care. Clin Med. 2022;22:423–33.CrossRef
29.
Saqib A, Atif M, Ikram R, Riaz F, Abubakar M, Scahill S. Factors affecting patients’ knowledge about dispensed medicines: a qualitative study of healthcare professionals and patients in Pakistan. PLoS ONE. 2018;13:e0197482.CrossRefPubMedPubMedCentral
30.
Searle RH, Rice C, McConnell AA, Dawson JF. Bad apples? Bad barrels? Or bad cellars? Antecedents and processes of professional misconduct in UK Health and Social Care: Insights into sexual misconduct and dishonesty. 2017.
31.
Pereira-Lima K, Mata DA, Loureiro SR, Crippa JA, Bolsoni LM, Sen S. Association between physician depressive symptoms and medical errors: a systematic review and meta-analysis. JAMA Netw Open. 2019;2:e1916097.CrossRefPubMedPubMedCentral
32.
Brown SD, Goske MJ, Johnson CM. Beyond substance abuse: stress, Burnout, and Depression as causes of Physician Impairment and disruptive behavior. J Am Coll Radiol. 2009;6:479–85.CrossRefPubMed
33.
Bradfield OM, Bismark M, Scott A, Spittal M. Vocational and psychosocial predictors of medical negligence claims among Australian doctors: a prospective cohort analysis of the MABEL survey. BMJ Open. 2022;12:e055432.CrossRefPubMedPubMedCentral
34.
Kenna GA, Wood MD. Prevalence of substance use by pharmacists and other health professionals. J Am Pharm Assoc. 2004;44:684–93.CrossRef
35.
Surgenor LJ, Diesfeld K, Kersey K, Ip M. Practitioner health issues featuring before New Zealand’s health practitioners disciplinary Tribunal: an analysis of cases 2003–2014. J Law Med. 2017;24:590–6.PubMed
36.
37.
Lianov L. A powerful antidote to physician burnout: intensive healthy lifestyle and positive psychology approaches. Am J Lifestyle Med. 2021;15:563–6.CrossRefPubMedPubMedCentral
38.
Bradfield O, Jenkins K, Spittal M, Bismark M. Australian and New Zealand doctors’ experiences of disciplinary notifications, investigations, proceedings and interventions relating to alleged mental health impairment: a qualitative analysis of interviews. Int J Law Psychiatry. 2023;86:101857.
39.
Bradfield OM, Bismark MM, Spittal MJ, O’Brien P. The publication of impaired doctors’ identity by Australian and New Zealand tribunals: law, practice, and reform. Med Law Rev. 2023;31:391–423.CrossRefPubMedPubMedCentral
40.
Wexler DB, Winick BJ. Law in a therapeutic key: developments in therapeutic jurisprudence. Curr Issues Crim Justice. 1997;8:337–40.CrossRef
41.
Wang Y, Ram S, Scahill S. Risk identification and prediction of complaints and misconduct against health practitioners: a scoping review. Int J Qual Health Care. 2024;36:mzad114.
Metadata
Title
Characteristics and risk factors of pharmacist misconduct in New Zealand: a retrospective nationwide analysis
Authors
Yufeng Wang
Sanyogita (Sanya) Ram
Shane Scahill
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-024-10591-2

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue

Research

Patients’ experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation

Research

Strategies to improve care for older adults who present to the emergency department: a systematic review

Research

Macro level system mapping of the provision of mental health services to young people living in a conflict context in Colombia

Research

End-of-life and bereavement support to families in cancer care: a cross-sectional survey with bereaved family members

Research

Responsible coordination of municipal health and care services for individuals with serious mental illness: a participatory qualitative study with service users and professionals

Research

A step closer towards achieving universal health coverage: the role of gender in enrolment in health insurance in India